ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.

Name: ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.
Author: Ariceta, Gema

ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria. — المؤلف: Ariceta, Gema — Pediatric nephrology (Berlin, Germany) 20221221

المؤلف: Ariceta, Gema
النشر: Pediatric nephrology (Berlin, Germany) 20221221
الوصف: 403-415 p.
الموضوعات: Humans؛ Hyperoxaluria؛ Hyperoxaluria, Primary؛ Oxalobacter formigenes؛ Oxalates؛ Kidney Calculi